Polymorphisms in K13 and Falcipain-2 Associated with Artemisinin Resistance Are Not Prevalent in Plasmodium falciparum Isolated from Ugandan Children
about
Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient dataAntimalarial Drug Resistance: Literature Review and Activities and Findings of the ICEMR NetworkMonitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in TanzaniaDrug resistance genomics of the antimalarial drug artemisininRecent advances in malaria genomics and epigenomicsSustained efficacy of artesunate-sulfadoxine-pyrimethamine against Plasmodium falciparum in Yemen and a renewed call for an adjunct single dose primaquine to clear gametocytesGenetically Determined Response to Artemisinin Treatment in Western Kenyan Plasmodium falciparum ParasitesPlasmodium falciparum Resistance to Artemisinin Derivatives and Piperaquine: A Major Challenge for Malaria Elimination in Cambodia.A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.High throughput resistance profiling of Plasmodium falciparum infections based on custom dual indexing and Illumina next generation sequencing-technology.Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates.Artemisinin resistance-associated polymorphisms at the K13-propeller locus are absent in Plasmodium falciparum isolates from Haiti.Polymorphisms in Plasmodium falciparum K13-propeller in Angola and Mozambique after the introduction of the ACTs.Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker.The past, present and future use of epidemiological intelligence to plan malaria vector control and parasite prevention in UgandaPrevalence of K13-propeller polymorphisms in Plasmodium falciparum from China-Myanmar border in 2007-2012Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from ugandan children.Observing in real time the evolution of artemisinin resistance in Plasmodium falciparumPolymorphisms in the K13-propeller gene in artemisinin-susceptible Plasmodium falciparum parasites from Bougoula-Hameau and Bandiagara, MaliSlow Clearance of Plasmodium falciparum in Severe Pediatric Malaria, Uganda, 2011-2013.Lack of Artemisinin Resistance in Plasmodium falciparum in Uganda Based on Parasitological and Molecular AssaysPrevalence of K13-propeller gene polymorphisms among Plasmodium falciparum parasites isolated from adult symptomatic patients in northern Uganda.Induction of Multidrug Tolerance in Plasmodium falciparum by Extended Artemisinin Pressure.Artemisinin resistance at the China-Myanmar border and association with mutations in the K13 propeller geneUnderstanding artemisinin-resistant malaria: what a difference a year makesA Single Mutation in K13 Predominates in Southern China and Is Associated With Delayed Clearance of Plasmodium falciparum Following Artemisinin Treatment.Artesunate treatment of severe pediatric malaria: A review of parasite clearance kinetics and clinical implications.Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapyEmergence of Mutations in the K13 Propeller Gene of Plasmodium falciparum Isolates from Dakar, Senegal, in 2013-2014.In Vivo Efficacy and Parasite Clearance of Artesunate + Sulfadoxine-Pyrimethamine Versus Artemether-Lumefantrine in Mali.Limited artemisinin resistance-associated polymorphisms in Plasmodium falciparum K13-propeller and PfATPase6 gene isolated from Bioko Island, Equatorial GuineaK13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa.Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial.Little Polymorphism at the K13 Propeller Locus in Worldwide Plasmodium falciparum Populations Prior to the Introduction of Artemisinin Combination Therapies.Artemisinin-Resistant Plasmodium falciparum Malaria.Failure of dihydroartemisinin plus piperaquine treatment of falciparum malaria by under-dosing in an overweight patient.Limited genetic diversity in the PvK12 Kelch protein in Plasmodium vivax isolates from Southeast AsiaCharacterizing the impact of sustained sulfadoxine/pyrimethamine use upon the Plasmodium falciparum population in MalawiPlasmodium falciparum Genetic Diversity in Continental Equatorial Guinea before and after Introduction of Artemisinin-Based Combination Therapy
P2860
Q26783902-F3A65732-9D1D-41D7-BBDA-F480CCA0BCF0Q26799713-872AB9AC-937B-4F0A-A3AA-CB089314DEF4Q26820807-0DE598A3-497A-49AA-B1FC-ECB5DE0203D8Q26862789-89A48868-EC19-400F-AEF7-E1ACEA417B17Q28069435-B1EF1CD0-F009-47AC-8648-F8F3434F4BA8Q28125936-ED1D61CA-F646-4609-906B-13980D94592DQ28554000-587BDFA8-72DA-42CF-9B23-1E2BC65B8CBFQ30240158-6D967B83-FB7E-42F0-AE5B-1354571C2516Q30379780-40FDF7AF-404C-466F-9866-48B14EC8B4D2Q33729200-1D22263C-5027-4497-9C96-64EB5406D2BDQ34891749-C3B0158A-6AE4-4EAF-8D77-13E8F336077AQ35146682-557E2F9D-4F28-40C9-BB06-6337625942F6Q35150295-FF6E43E3-CDAB-45DC-B083-8DD949FFCABEQ35196116-D0061631-46AE-44DD-B2B1-0759F4163F09Q35217991-69E20521-72D0-4677-9CF2-8D7A0D4DB173Q35440004-634E2EB6-A126-4712-9E00-9B138F2A72FAQ35497094-8045BC35-5479-488A-ADA7-740D81C2E5C7Q35607844-84BEDFA5-23CF-4913-9529-CB650A0B8CFEQ35608785-4F0293C6-65A5-4DF3-A63E-18F5F0C7BEE2Q35616221-5CF43E20-48C2-44AA-9ED9-9FD4FA337EDCQ35780311-C262C497-0404-46E4-9D8F-63B9D3E253D5Q35860091-72CCAE87-61DB-4A21-AF21-C12C344B6A03Q36108352-079B7DE1-13B6-4467-AFEB-A22334611B94Q36121601-423734D3-3B0B-4372-9B48-C12FD56B7DF9Q36158329-60B6E13E-7BAE-4A01-9559-B26F529AA817Q36181160-422915B6-0A6A-42A8-9353-9C69BBEB4D74Q36208579-B2D85CB2-AA93-4ADA-A5AF-AFC4719EC9E6Q36277347-D63B9C35-C1E1-4395-9E00-AE8280975314Q36370090-5B4FA713-3BE6-40DF-B9D5-8F160C9A49D7Q36439084-E692BD57-8199-4C6C-8CDC-EEDE8A239446Q36644511-F4EE5F3F-D1E1-440D-94D0-F25F6DDA6468Q36724050-A30F55D5-D837-4235-84A4-BBDE624674CBQ36786733-ED04FB3B-DA3A-41F2-9D91-D8893E2F9522Q36812874-19ED26ED-F2FF-4860-959D-D02D8615F96BQ36933412-BF47E0BC-8F8F-4E34-9BAE-31066FFAFECEQ37193474-F02A74C2-7E07-4252-9F20-AB66BAB0AC5FQ37267688-0ADE19F5-83DC-402D-AA68-63550A7552A8Q37400685-91D0C149-843E-4869-8F4D-1C05290AE008Q37456812-A7FBF177-04FC-4C01-B382-527C2CB1B94CQ37538729-61387ED4-7098-4B26-A05E-168B82CB913C
P2860
Polymorphisms in K13 and Falcipain-2 Associated with Artemisinin Resistance Are Not Prevalent in Plasmodium falciparum Isolated from Ugandan Children
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Polymorphisms in K13 and Falci ...... Isolated from Ugandan Children
@ast
Polymorphisms in K13 and Falci ...... Isolated from Ugandan Children
@en
Polymorphisms in K13 and Falci ...... Isolated from Ugandan Children
@nl
type
label
Polymorphisms in K13 and Falci ...... Isolated from Ugandan Children
@ast
Polymorphisms in K13 and Falci ...... Isolated from Ugandan Children
@en
Polymorphisms in K13 and Falci ...... Isolated from Ugandan Children
@nl
altLabel
Polymorphisms in K13 and falci ...... isolated from Ugandan children
@en
prefLabel
Polymorphisms in K13 and Falci ...... Isolated from Ugandan Children
@ast
Polymorphisms in K13 and Falci ...... Isolated from Ugandan Children
@en
Polymorphisms in K13 and Falci ...... Isolated from Ugandan Children
@nl
P2093
P2860
P50
P921
P3181
P1433
P1476
Polymorphisms in K13 and Falci ...... Isolated from Ugandan Children
@en
P2093
James Kapisi
Mary Muhindo
Melissa D Conrad
Victor Bigira
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0105690
P407
P577
2014-01-01T00:00:00Z